- Filed
- Apr 30, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 55.83M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.15B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.15B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $109.62M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $110.52M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $394.71M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $377.26M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $969.85M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $878.8M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.28B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.19B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.73B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.65B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.63B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.52B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $3.38B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 57.64M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $110.41M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $41.28M |
| Capex | Q1 2025 · Mar 31, 2024 | $26.26M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $133.29M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.31B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.31B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $2.14 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $2.17 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $198.75M |
| Net Income | Q1 2025 · Mar 31, 2024 | $123.42M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $165.05M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $368.4M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $612.8M |
| Revenue | Q1 2025 · Mar 31, 2024 | $981.2M |